Kyntra Bio, Inc.
KYNB
$7.94
-$0.10-1.22%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 183.19M | 163.62M | 183.45M | 215.65M | -2.07M |
| Total Depreciation and Amortization | 213.00K | 428.00K | 748.00K | 1.09M | 1.64M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -70.64M | -38.31M | -35.94M | -37.69M | 15.82M |
| Change in Net Operating Assets | -150.82M | -147.11M | -153.03M | -195.97M | -38.83M |
| Cash from Operations | -38.05M | -21.38M | -4.77M | -16.91M | -23.44M |
| Capital Expenditure | -9.00K | -22.00K | -38.00K | -179.00K | -252.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 206.00K | 1.04M |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | 100.55M | 96.56M | 96.62M | 90.20M | -- |
| Other Investing Activities | -44.40M | -58.08M | -61.16M | -1.38M | 1.66M |
| Cash from Investing | 56.14M | 38.45M | 35.42M | 88.85M | 2.45M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -80.56M | -80.56M | -80.56M | -80.56M | -22.00K |
| Issuance of Common Stock | -- | -- | -- | 23.00K | 23.00K |
| Repurchase of Common Stock | -32.00K | -39.00K | -69.00K | -75.00K | -174.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -5.35M | -5.35M | -5.40M | -5.40M | -46.00K |
| Cash from Financing | -85.94M | -85.95M | -86.03M | -86.01M | -219.00K |
| Foreign Exchange rate Adjustments | -1.34M | -329.00K | 1.08M | 1.04M | 338.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -69.20M | -69.20M | -54.31M | -13.03M | -20.87M |